The death of a 16-year-old boy evokes a lengthy battle to realize the benefit of cutting-edge gene therapy while also ...
After a patient taking the Duchenne muscular dystrophy gene therapy Elevydis died of liver injury ... Meanwhile, in November 2022, an FDA-sanctioned trial from the non-profit biotech Cure Rare Disease ...
No human infections have been identified. More information and details about the recall can be found at the FDA website.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results